Table 2.
Cox regression analysis for prognosis in OSCC patients.
| Overall survival | B | SE | Wald | df | P value | Exp(B) | 95%Exp(B) |
|
|---|---|---|---|---|---|---|---|---|
| upper limit | Lower limit | |||||||
| SAMMSON | 1.277 | 0.629 | 4.117 | 1 | 0.042 | 3.586 | 1.044 | 12.315 |
| Tumor differentiation | 0.21 | 0.412 | 0.259 | 1 | 0.0351 | 1.254 | 0.55 | 2.854 |
| TMN stage | −1.473 | 0.489 | 9.08 | 1 | 0.003 | 0.229 | 0.088 | 0.598 |
| Lymphatic metastasis | −1.237 | 0.459 | 8.72 | 1 | 0.035 | 1.984 | 0.605 | 0.998 |
| Distant metastasis | −0.797 | 0.392 | 4.133 | 1 | 0.042 | 0.451 | 0.209 | 0.972 |
| Cancer invasion depth (8 mm) | −0.998 | 0.542 | 7.33 | 1 | 0.027 | 0.179 | 0.025 | 0.993 |
| Tumor location | 0.11 | 0.17 | 0.42 | 1 | 0.517 | 1.116 | 0.8 | 1.557 |
| Tumor size | −0.115 | 0.182 | 0.398 | 1 | 0.528 | 0.897 | 0.624 | 1.274 |
| Sex | −0.002 | 0.016 | 0.017 | 1 | 0.895 | 0.998 | 0.967 | 1.03 |
| Age | −0.275 | 0.51 | 0.292 | 1 | 0.589 | 0.759 | 0.28 | 2.062 |